Announcements Trials
Browse Landscape

Phase

Phase NA 55Phase 2 6Phase 3 4Phase 4 3Phase 2/3 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 2Gynecologic 1Endocrine 1

Conditions

Obesity 2Weight Loss 1Sexual Dysfunction, Physiological 1Protein Deficiency 1Overweight 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Malnutrition 1Inflammation 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Nutrition Assessment × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT04687124 2020-12-29

EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy -

University of Copenhagen

Phase 4 Unknown
26 enrolled

Protein Deficiency, Weight Loss, Malnutrition

NCT01554735 2015-07-29

Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men

Changi General Hospital

Phase 4 Completed
70 enrolled
EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡